Ride To Crush COVID-19

JUNE 1-6, 2021

2021 Annual Canada Africa Partnership Ride

Ride to support the rights of women and girls!

Thank you for JOINing THE Canada Africa Partnership Ride

Thank you to all who participated and donated to the Canada Africa Partnership Ride. During the month of June, we had 28 riders and we raised just over $9,000!


 

For the past year, Crossroads International has been raising unrestricted funds for a COVID-19 emergency response in support of women and girls in sub-Saharan Africa who have become even more vulnerable to the basic issues of livelihood, hunger and safety. This is why we need your help to support them and crush COVID-19 globally.

When you register, you have the option of joining Team Crossroads or forming your very own team in support of Team Crossroads! If you know 2 or more people who would like to join you on this virtual ride-a-thon, we encourage you to form your own team!

With your support, we hope to raise $25,000 from the seat of our bikes toward a goal of $250,000 to support local partners facing this global pandemic.

Do you want to fundraise for Team Crossroads but you don’t really know how? Here are some fundraising tips to learn how to raise $250, $500 or $1000 as well as a donor checklist for you to help you have a better vision of your network potential.

EVENT SCHEDULE

WHERE WILL YOUR MONEY GO?

The money raised will be used to invest in local partner organizations in 7 African countries where we operate and will help adapt existing programs to deliver essential services and respond to urgent needs brought on by the pandemic. This includes providing outreach and counseling services for survivors of domestic violence, sexual trafficking, and basic resources such as food, disinfectants, masks, and cleaning supplies. The funds will also be used to strengthen the long-term resilience of food systems and livelihoods for women in rural and marginalized communities.

Join the virtual movement, stand with us and challenge yourself! Together we can crush COVID-19.